ArticleBreast cancer research and treatment2024

Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study.

Kai-Ye Du et al.PubMed ↗Publisher ↗

No numbers read from the abstract.